-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Poster Walk on Diversity, Equity and Inclusion(DEI) in Hematology

Program: ASH Poster Walks
Hematology Disease Topics & Pathways:
Research, Biological therapies, Clinical Practice (Health Services and Quality), Non-Biological therapies, Clinical Research, health outcomes research, Workforce, Diversity, Equity, and Inclusion (DEI) , health disparities research, drug development, real-world evidence, Therapies, Study Population, Human
Thursday, December 14, 2023: 10:00 AM-11:00 AM
(Virtual Program)
This poster walk will highlight works that investigate structural barriers impacting provision of care across hematology for patients from underserved racial/ ethnic groups, those of lower socio-economic status, and other vulnerable groups. In particular, the poster walk will spotlight research that advances efforts to diversify patient populations, mitigate barriers to care, and maximize the equitable provision of optimal care for marginalized or under-privileged groups. The walk will also feature posters outlining work being done to make our field more inclusive for patients, donors, and caregivers, as well as for practitioners across the hematology workforce. It will serve to connect stakeholders in Diversity, Equity, and Inclusion (DEI) in hematology, and facilitate discussions on the state of DEI research in the field. This walk is well aligned with ASH Research Agenda to advance equity both in the U.S. and globally.

Lauren E. Merz, MD, MSc1,2, Alexander Chaitoff, MD, MPH3*, Angela C Weyand, MD4, Michael Fralick, MD, PhD5* and Michelle Sholzberg, MDCM, MSc6

1Mass General Brigham, Boston
2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
3Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA
4Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI
5University of Toronto, Toronto, ON, Canada
6Division of Hematology-Oncology, St. Michael's Hospital, Toronto, ON, Canada

Ijele Adimora, MD, MBA1, Luisanna M Sanchez Ventura, MD2 and Jonathan M. Flanagan, PhD2

1The Johns Hopkins University School of Medicine, Baltimore, MD
2Texas Children's Cancer & Hematology Center, Baylor College of Medicine, Houston, TX

Lauren Laufer, MS, BA1, Lemchukwu Amaeshi, MD2, Alex Sisto, MD3*, Kateryna Fedorov, MD4,5, Rosmi Mathew6*, David Levitz, MD5, Ioannis Mantzaris5, Noah Kornblum, MD5, Mendel Goldfinger, MD5*, Alejandro Sica, MD5*, Dennis L Cooper, MD5, Marina Y. Konopleva5,7, Bruce Rapkin6*, Amit Verma, MD8, Aditi Shastri, MD9 and Nishi Shah, MBBS, MPH5

1Albert Einstein College Of Medicine/Montefiore Medical Center, Bronx, NY
2Montefiore Medical Center, Bronx, NY
3Montefiore Medical Center and Albert Einstein College of Medicine, Bronx
4Oncology, Vanderbilt University Medical Center, Nashville, NY
5Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
6Montefiore Medical Center, Bronx
7Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Medical Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
9Blood Cancer Institute, Department of Oncology, Albert Einstein College of Medicine, Bronx, NY

Morohuntodun O. Oni1,2*, Alexandria Hawkins, BS2,3*, Emily Stein2,4*, Steven G. Dubois, MD, MS2,3,5*, Katie A. Greenzang, MD, EdM2,3,5,6*, Rahela Aziz-Bose, MD2,3,5,6, Christine Duncan, MD2,3,5, Allison F. O'Neill, MD2,3,5*, Andrew E. Place, MD, PhD2,3,5, Puja J. Umaretiya, MD2,3,5,6*, Natasha Archer, MD2,5,7 and Kira Bona, MD, MPH2,3,5,6

1Dana-Farber / Boston Children’s Cancer and Blood Disorders Center, Brookline, MA
2Division of Pediatric Hematology/Oncology, Boston Children’s Hospital, Boston, MA
3Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
4Dana-Farber / Boston Children’s Cancer and Blood Disorders Center, Boston, MA
5Department of Pediatrics, Harvard Medical School, Boston, MA
6Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA
7Dana-Farber/Boston Children's Cancer and Blood Disorder Ctr., Boston, MA

Zalaya K Ivy, MD, MS1, Sharon Hwee, MPH2*, Brittany C Kimball, MD3, Michael D Evans, MS1*, Catherine M Bendel, MD4* and Alex A Boucher, MD1

1University of Minnesota, Minneapolis, MN
2University of Minnesota/Masonic Cancer Center, Minneapolis, MN
3Division of Hematology/Oncology, Mayo Clinic College of Medicine and Science, Rochester, MN
4Department of Pediatrics, Division of Neonatology, University of Minnesota Medical School, Minneapolis, MN

See more of: ASH Poster Walks